| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| PTH |
P01270
|
parathyroid hormone
|
|
1.2E-02 |
0.397 |
0.846 |
| MGMT |
P16455
|
O-6-methylguanine-DNA methyltransferase
|
|
1.2E-07 |
0.412 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| MITF |
O75030
|
melanocyte inducing transcription factor
|
|
0.98 |
0.499 |
0.808 |
| NPPA |
P01160
|
natriuretic peptide A
|
|
5.5E-04 |
0.505 |
0.769 |
| TERF2IP |
Q9NYB0
|
TERF2 interacting protein
|
|
2.7E-05 |
0.548 |
0.731 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| ACD |
Q96AP0
|
ACD shelterin complex subunit and telomerase recruitment factor
|
|
1.1E-12 |
0.603 |
0.731 |
| IFNA17 |
P01571
|
interferon alpha 17
|
|
|
0.636 |
0.615 |
| CMM |
|
cutaneous malignant melanoma/dysplastic nevus
|
|
|
0.670 |
0.385 |
| XRS |
|
X-ray sensitivity
|
|
|
0.716 |
0.500 |
| TERT |
O14746
|
telomerase reverse transcriptase
|
Enzyme
|
0.99 |
0.374 |
0.846 |
| BAP1 |
Q92560
|
BRCA1 associated protein 1
|
Enzyme
|
0.99 |
0.454 |
0.731 |
| TYR |
P14679
|
tyrosinase
|
Enzyme
|
5.0E-32 |
0.473 |
0.808 |
| HPRT1 |
P00492
|
hypoxanthine phosphoribosyltransferase 1
|
Enzyme
|
0.94 |
0.500 |
0.808 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| MC1R |
Q01726
|
melanocortin 1 receptor
|
G-protein coupled receptor
|
8.1E-11 |
0.524 |
0.808 |
| CHRM1 |
P11229
|
cholinergic receptor muscarinic 1
|
G-protein coupled receptor
|
0.99 |
0.653 |
0.577 |
| CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
| CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |